Details of issuance or disposal
Monthly exercise status of the First Series Stock Acquisition Rights issued through a third-party allotment (fixed exercise price type)
Number of shares delivered during the month: 84,000 new shares (0 treasury shares transferred)
Exercise ratio during the month: 4.00% (relative to the total of 21,000 rights issued)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the First Series Stock Acquisition Rights issued through a third-party allotment (fixed exercise price type) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 84,000 new shares (0 treasury shares transferred) |
| Dilution Rate | Exercise ratio during the month: 4.00% (relative to the total of 21,000 rights issued) |
| Total number of issued shares | Number of shares issued and outstanding at the end of the month preceding the target month: 1,914,733 shares → Not disclosed |
| Exercise price | ¥2,295 per share. These are fixed exercise price-type rights, and the exercise price will not be adjusted. |
| Number of Stock Acquisition Rights | Total issued: 21,000 rights; unexercised at the end of the month preceding the target month: 16,525 rights; unexercised at the end of the target month: 15,685 rights |
| Most recent equity financing | First Series Stock Acquisition Rights issued on 15 December 2025 (detailed amount: Not disclosed) |
Items this document does not state (21)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fixed exercise price-type Stock Acquisition Rights, the monthly exercise status is disclosed, in accordance with the practice for variable exercise price-type rights, from the perspective of information disclosure to shareholders and investors.